NHS FDP Cancer 360 dominated the headlines last month as Government announced it is to be rolled out across the NHS. Initially piloted at Chelsea and Westminster NHS Foundation Trust’s gynaecology ...

At a recent AstraZeneca UK sponsored HSJ roundtable event for NHS stakeholders, I had the privilege of hearing directly from ...

A hospital trust which is continuing to lag behind with several national cancer targets says it is seeing “positive changes”.

The “future already looks better for the NHS” under Labour, Sir Keir Starmer has said, as he published a radical plan to ...

The number of patients receiving cancer treatments on time and within targets has hit its lowest point since records began in ...

The three Cancer Vanguard hospital trusts – The Christie NHS Foundation Trust, the Royal Marsden NHS Foundation Trust and University College London Hospitals NHS Foundation Trust (UCLH ...

New plans have been announced to shake up the way cervical cancer risk is detected in England: at-home HPV testing kits are ...

A total of 95.8 per cent of patients being seen within 62 days in Lanarkshire from January to March this year.

“Targeted actions are underway across all our cancer pathways to increase capacity, speed up diagnosis and treatment and deliver care more efficiently. “Like many NHS trusts, we have seen ...

How new diagnostic pathways can support earlier diagnosis and appropriate management in patients with lower gastrointestinal ...

Experts and researchers have been looking into which foods could help reduce one's risk of developing cancer and how some are ...

The NHS said in a statement, "Belantamab mafadotin -- which was research and developed in the UK -- is an antibody-drug conjugate, a type of treatment which targets and attaches to cancer cells.